TEVA Headlines | Teva Pharmaceutical Industries Stock - Yahoo! Finance

Thu, May 2, 2013, 7:54AM EDT - U.S. Markets open in 1 hr 36 mins

Dow

0.94% Nasdaq

0.89%

More On TEVA

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

Teva Pharmaceutical Industries Limited (TEVA)

-NYSE

38.10 May 1, 4:04PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Thursday, May 2, 2013

Teva Pharm quarterly profit falls less than expectedat Reuters (Thu 7:23AM EDT)
Teva Reports First Quarter 2013 ResultsBusiness Wire (Thu 7:00AM EDT)

Wednesday, May 1, 2013

Tuesday, April 30, 2013

[$$] FDA Lowers Age Restriction on Plan Bat The Wall Street Journal (Tue, Apr 30)
Teva confirms over-the-counter availability of Plan Bat theflyonthewall.com (Tue, Apr 30)
InPlay: Teva Pharma confirms FDA approves over-the-counter availability of Plan B One-Step (levonorgestrel) tablet 1.5 mg for consumers 15 and overBriefing.com (Tue, Apr 30)
FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and OverBusiness Wire (Tue, Apr 30)
FDA Allows 'Morning After Pill' To Be Sold To Some Teenagers Without A Prescriptionat Forbes (Tue, Apr 30)
Bayer Aims to Expand HealthCare PortfolioZacks (Tue, Apr 30)
Forbes Earnings Preview: Teva Pharmaceutical Industriesat Forbes (Tue, Apr 30)
OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for EnrollmentCNW Group (Tue, Apr 30)
OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for EnrollmentPR Newswire (Tue, Apr 30)

Monday, April 29, 2013

Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA)at TheStreet (Mon, Apr 29)
Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy OfficerBusiness Wire (Mon, Apr 29)

Sunday, April 28, 2013

Teva Pharmaceuticals Is A Bitter Pill To Swallowat Seeking Alpha (Sun, Apr 28)

Friday, April 26, 2013

Teva's 3 Biggest Challengesat Motley Fool (Fri, Apr 26)
Orphan Drug Status for Teva/Xenon DrugZacks (Fri, Apr 26)
Wall Street Transcript Interview with Ramin Najafi, Founder, Chairman and CEO of NovaBay Pharmaceuticals, Inc. (NBY)Wall Street Transcript (Fri, Apr 26)

Thursday, April 25, 2013

Which One Should Investors Buy: The Ex-Parent or the Spin-off?at Motley Fool (Thu, Apr 25)

Older Headlines

Add TEVA News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.